drugset
drugset / Trial / NCT04671953

Effect of BMS-986165 on the Blood Levels of Metformin

NCT04671953 ↗

Phase 1 Completed 36 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the effects of BMS-986165 on the drug levels of metformin in healthy participants.

Timeline

Start
2020-12-18
Primary completion
2021-03-03
Completion
2021-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule — —
Subject Metformin Small molecule — —

Indications

No indication recorded.